Barely Significant
← all excerpts

Efficacy and safety of targeting VEGFR drugs in treatment for advanced or metastatic gastric cancer: a systemic review and meta-analysis.

Oncotarget · 2018 · PMC5814287 · PMID 29487720

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

a significant trendP < 0.001actually significant
Meanwhile, targeting VEGFR drugs had a significant trend of decreasing PDR compared with the control arms (OR 0.45, 95% CI (0.34, 0.59), P < 0.001, Figure 5 ).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.